
Helen Robbins
@h_l_robbins
NIHR Academic Clinical Lecturer, Medical Oncology at University of Birmingham. Oncology Registrar. Cancer research. Views are my own.
ID: 841243760650514432
13-03-2017 11:05:16
37 Tweet
32 Takipçi
104 Takip Edilen





In this new article in Annals of Oncology, Charles Swanton at al. review and discuss results from three genotype matched platform trials, drawing a roadmap for a future precision medicine strategy 🧬🎯💊 annalsofoncology.org/article/S0923-…



It’s finally in print! Our paper Cell Reports Medicine looking at using a digital AI reader make by Sensyne Health to increase the accuracy of interpretation of LFDs - props to many people listed below - paper is here: cell.com/cell-reports-m…




Excited to be launching our first series of multi-language #patient info tmr. A small step towards #equitable access to high-quality info about #genetic testing in #ovariancancer. Wellcome Sanger Institute BGCS fellows Beggs Lab Professor Khalid Khan Professor Shakila Thangaratinam Emma Crosbie Sudha Sundar


Andrew Beggs (Cancer and Genomic Sciences) discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers Listen to the full episode👉bit.ly/48Ry09y #lcsm #MedTwitter





📢New ESMO - Eur. Oncology guidelines in press - Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Professor Georgina Long AO (Bluesky @gvlongphdmd) @beckilee Teresa Amaral, MD, PhD Omid Hamid MD The Angeles Clinic @matguc Marco Donia doi.org/10.1016/j.anno…


PhD position available in the Jones lab! warwick.ac.uk/fac/cross_fac/… MIBTP programme. Understanding how DNA replication and the nuclear membrane deteriorate with age. With Zita Balklava Aston University Application deadline 16th Jan 2025

✨New Paper✨ Is mTORC1/2 inhibition effective in STK11 deficient NSCLC? (Arm B2, National Lung Matrix Trial) Real pleasure working with this fab team, key mentions: Lucinda Billingham, Josh the Savage joshsavage.bsky.social, Andrew Beggs,Birmingham Cancer Research UK Clinical Trials Unit, (Gary Middleton, not on twitter) nature.com/articles/s4169…